TP53 and B-cell non-Hodgkin lymphoma: Unfavorable outcome was also observed in B-cell lymphoma patients (N=52) with mutated TP53 gene (P=0.0086, Figure 4C), mutated TP53 pathway (P=0.013, Figure 4D), and mutated Hippo pathway (P=0.0038, Figure 4E).